Clinical Trial Update: Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of DaxibotulinumtoxinA for Injection in adults with upper limb spasticity has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Limb Spasticity

Drugs mentioned

• DaxibotulinumtoxinA for Injection (daxibotulinumtoxinA)

Snippet

Sponsor: Revance Therapeutics, Inc. | Conditions: Upper Limb Spasticity | Phase 2 | Status: COMPLETED | Results posted: 2023-09-21